Global /South Korea /Healthcare /Drug Manufacturers - Specialty & Generic /036480

Daesung Microbiological Labs. Co., Ltd.

036480

• KRX: 036480 • Delayed

7,480KRW -0.8%

4.88 USD

As of 5 June 2026, Daesung Microbiological Labs. Co., Ltd. has a market cap of $18.54M USD, ranking #37656 globally and #2396 in South Korea. It ranks #3365 in the Healthcare sector, and #210 in the Drug Manufacturers - Specialty & Generic industry.

Global Rank

37656

Country Rank

2396

Sector Rank

3365

Industry Rank

210

Key Stats

Market Cap

$18.54MUSD

28.42B KRW

Enterprise Value

$25.45MUSD

39.01B KRW

Revenue (TTM)

$16.95MUSD

25.99B KRW

EBITDA (TTM)

$2.12MUSD

3.25B KRW

Net Income (TTM)

$390.25KUSD

598.19M KRW

EBITDA Margin

13%

Profit Margin

2.3%

PE Ratio

47.5

PS Ratio

1.1

PB Ratio

0.8

EV/EBITDA

12.1

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Hang-Won Cho open_in_new

Employees

134

Founded

1966

Website

dsmbio.co.kr open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.8%	0.8%	-13%	5.4%	1.9%	2.5%	-12%	-23%	-62%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	036480 (주)대성미생물연구소 ISIN: KR7036480002 Shares Out.: Shares Outstanding: 3.8M¹ Shares Float: 2.28M² TV: TradingView: KRX: 036480 SA: Stock Analysis: KRX: 036480 YF: Yahoo Finance: 036480.KS GF: Google Finance: KRX: 036480 BA: Barron's: 036480 MS: Morningstar: XKRX: 036480	7,480 KRW	TV: TradingView: KRX: 036480 SA: Stock Analysis: KRX: 036480 YF: Yahoo Finance: 036480.KS GF: Google Finance: KRX: 036480 BA: Barron's: 036480 MS: Morningstar: XKRX: 036480

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Daesung Microbiological Labs. Co., Ltd.

Daesung Microbiological Labs. Co., Ltd. manufactures and sells vaccines for swine, poultry, canine, cattle, and fish in South Korea. It offers antibiotics and antibacterials, parasiticides and disinfectants, probiotics and enzyme products, and nutrients and pharmaceuticals. The company also exports its products. Daesung Microbiological Labs. Co., Ltd. was founded in 1966 and is headquartered in Uiwang-si, South Korea.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Myung In Pharmaceutical LTD. KRX: 317450	$539.11M 826.36B KRW 3K%	8.4	South Korea
FutureChem Co.,Ltd KRX: 220100	$278.08M 426.25B KRW 1K%	-	South Korea
KOLMAR BNH Co.,Ltd. KRX: 200130	$218.56M 335.01B KRW 1K%	-	South Korea
Kwang Dong Pharmaceutical Co., Ltd. KRX: 009290	$203.29M 311.61B KRW 996%	16.3	South Korea
NOVAREX Co.,Ltd. KRX: 194700	$167.22M 256.31B KRW 802%	7.4	South Korea
Kyung Dong Pharmaceutical Co., Ltd. KRX: 011040	$98.78M 151.41B KRW 433%	17.8	South Korea

Industry: Drug Manufacturers - Specialty & Generic (Global)

Name	Market Cap (USD) diff.	PE	Country
Teva Pharmaceutical Industries Ltd. TLV: TEVA	$37.66B 108.92B ILS 203K%	24.2	Israel
Revolution Medicines, Inc. NASDAQ: RVMD	$29.56B 159K%	-	United States
Zhejiang NHU Company Ltd. SHE: 002001	$15.86B 107.34B CNY 85K%	16.0	China
Cipla Ltd. NSE: CIPLA	$11.12B 1.06T INR 60K%	23.4	India
Lupin Ltd. NSE: LUPIN	$11.0B 1.05T INR 59K%	22.7	India
Haisco Pharmaceutical Group Co., Ltd. SHE: 002653	$9.1B 61.6B CNY 49K%	80.6	China

chevron_leftBack